We are live on ! Find out more
DR

David Rolfe Wedgewood Partners

AUM $484M
1-Year Est. Return 16.04%
 

David Rolfe is the chief investment officer of Wedgewood Partners, known for a concentrated growth portfolio of large-capitalization companies. The firm emphasizes quality franchises, high returns on capital, and limited diversification across only a few dozen names at most. Rolfe’s commentaries are followed by investors who prefer focused growth ownership over broad index replication.

This Fund
S&P 500
This Quarter Est. Return
+2.02%
1 Year Est. Return
+16.04%
3 Year Est. Return
+78.15%
5 Year Est. Return
+102.72%
10 Year Est. Return
+513.7%
AUM
$5.73B
AUM Growth
+$333M
Cap. Flow
+$250M
Cap. Flow %
4.36%
Top 10 Hldgs %
63.95%
Holding
22
New
1
Increased
17
Reduced
3
Closed
1

Top Buys

Rank Stock Value
1
TPR icon
Tapestry
TPR
+$184M
2
V icon
Visa
V
+$70.5M
3
BKNG icon
Booking.com
BKNG
+$53.9M
4
ESRX
Express Scripts Holding Company
ESRX
+$39.9M
5
PRGO icon
Perrigo
PRGO
+$35.1M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$135M
2
CMI icon
Cummins
CMI
+$87M
3
AAPL icon
Apple
AAPL
+$57.4M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$37.9M

Sector Composition

Rank Sector Weight
1 Technology 29%
2 Financials 17.69%
3 Healthcare 14.88%
4 Industrials 11.85%
5 Consumer Discretionary 10.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.51T
$560M 9.77%
24,106,736
-2,697,748
-10% -$57.4M
BRK.B icon
2
Berkshire Hathaway Class B
BRK.B
$1.06T
$512M 8.94%
4,048,166
-299,661
-7% -$37.9M
QCOM icon
3
Qualcomm
QCOM
$169B
$388M 6.77%
4,897,789
+220,710
+5% +$17.5M
ESRX
4
DELISTED
Express Scripts Holding Company
ESRX
$383M 6.68%
5,526,574
+566,837
+11% +$39.9M
EMC
5
DELISTED
EMC CORPORATION
EMC
$368M 6.42%
13,965,839
+1,089,195
+8% +$28.8M
CTSH icon
6
Cognizant
CTSH
$27.9B
$347M 6.05%
7,094,047
+427,858
+6% +$20.9M
MTB icon
7
M&T Bank
MTB
$34.7B
$302M 5.27%
2,435,410
+109,078
+5% +$13.3M
SRCL
8
DELISTED
Stericycle Inc
SRCL
$283M 4.94%
2,393,147
+175,803
+8% +$20.1M
TPR icon
9
Tapestry
TPR
$26B
$268M 4.68%
7,846,843
+4,286,022
+120% +$184M
SLB icon
10
SLB Ltd
SLB
$79.9B
$255M 4.44%
2,159,911
+67,981
+3% +$7.01M
PRGO icon
11
Perrigo
PRGO
$1.98B
$254M 4.43%
1,742,399
+247,620
+17% +$35.1M
GOOG icon
12
Alphabet (Google) Class C
GOOG
$4.18T
$243M 4.24%
8,407,841
+452,293
+6% +$12.3M
MJN
13
DELISTED
Mead Johnson Nutrition Company
MJN
$222M 3.87%
2,381,845
+66,509
+3% +$5.82M
VAR
14
DELISTED
Varian Medical Systems, Inc.
VAR
$216M 3.77%
2,966,601
+166,790
+6% +$12M
BKNG icon
15
Booking.com
BKNG
$158B
$211M 3.68%
4,379,800
+1,123,550
+35% +$53.9M
V icon
16
Visa
V
$693B
$200M 3.48%
3,790,812
+1,348,780
+55% +$70.5M
VRSK icon
17
Verisk Analytics
VRSK
$24.4B
$193M 3.37%
3,216,655
+354,596
+12% +$21.2M
CMI icon
18
Cummins
CMI
$80.9B
$185M 3.23%
1,202,145
-575,139
-32% -$87M
NOV icon
19
NOV
NOV
$7.28B
$181M 3.15%
2,196,060
+1,887
+0.1% +$141K
LKQ icon
20
LKQ Corp
LKQ
$6.52B
$144M 2.52%
5,408,348
+317,890
+6% +$8.78M
DNOW icon
21
DNOW Inc
DNOW
$2.83B
$17.3M 0.3%
+478,947
New +$16.5M
GILD icon
22
Gilead Sciences
GILD
$181B
– –
-1,907,287
Closed -$135M

Similar funds

PWM
Prentice Wealth Management Rochester, New York $484M AUM 13.77% 1-Year Est. Return
GVCM
Global View Capital Management Waukesha, Wisconsin $484M AUM 48.46% 1-Year Est. Return
FC
Foursixthree Capital New York $485M AUM 117.01% 1-Year Est. Return
AA
Ashford Advisors Pittsford, New York $485M AUM 21.08% 1-Year Est. Return
FMB
Field & Main Bank Henderson, Kentucky $485M AUM 34.26% 1-Year Est. Return
CPI
Crestview Partners IV New York $485M AUM 83.84% 1-Year Est. Return
CCA
Cadent Capital Advisors Tulsa, Oklahoma $485M AUM 45.96% 1-Year Est. Return
SCH
Shengqi Capital (HK) Hong Kong $484M AUM 300.05% 1-Year Est. Return

David Rolfe's Q2 2014 Portfolio in Review

As of Q2 2014, David Rolfe held 22 positions worth $5.73B, up 6.2% from $5.4B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

David Rolfe deployed $250M of net new capital in Q2 2014, opening 1 new position and adding to 17 existing holdings. Its largest new stake was DNOW Inc: 478,947 shares worth $17.3M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 29% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Cummins, an estimated $87M trimmed.

  • David Rolfe's largest Q2 2014 buy was DNOW Inc: 478,947 shares worth $17.3M.
  • David Rolfe added most to Tapestry in Q2 2014, an estimated $184M increase.
  • David Rolfe's biggest Q2 2014 reduction was Cummins, cutting an estimated $87M.
  • David Rolfe fully exited Gilead Sciences in Q2 2014, selling an estimated $135M.
  • David Rolfe's ten largest holdings make up 64% of its $5.73B portfolio in Q2 2014.
  • David Rolfe opened 1 new position and closed 1 in Q2 2014.
  • David Rolfe's portfolio value rose 6.2% quarter-over-quarter to $5.73B.

Based on Wedgewood Partners's 13F filing for Q2 2014, filed 14 Aug 2014.